Gene · 28935
Papers1,911
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,911
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Author Correction: Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation. | Nat Immunol | 2026 | 42773268 | PubTator, text mining | PubMed |
| CRISPR/Cas9 screening revealed BIRC6-AS1/BIRC6 mediates abiraterone resistance via NHEJ pathway-dependent A20 degradation in prostate cancer. | Oncogene | 2026 | 42754663 | PubTator, text mining | PubMed |
| Editorial comment on "Functional changes in the gut microbiota are associated with the intestinal phenotype in A20 haploinsufficiency". | Pediatr Allergy Immunol | 2026 | 42747403 | PubTator, text mining | PubMed |
| In-depth examination of the zinc-mitigation of the molecular effects of heat stress-induced intestinal damage in broilers. | Poult Sci | 2026 | 42731220 | PubTator, text mining | PubMed |
| Glucose hypometabolism gates tau-dependent necroptosis. | Neuron | 2026 | 42685677 | PubTator, text mining | PubMed |
| Truncating RELA variants drive autoinflammation and autoimmunity by impairing the negative feedback control of NF-κB. | JCI Insight | 2026 | 42579371 | PubTator, text mining | PubMed |
| Compartment-specific Zinc Misallocation in Diabetic Foot Ulcers: Mechanistic Coupling Between Macrophage M1 Locking and MMP-9 Hyperactivation. | Biol Trace Elem Res | 2026 | 42448958 | PubTator, text mining | PubMed |
| Cryptic RNA binding sites are energetically accessible and chemically addressable. | bioRxiv | 2026 | 42427657 | PubTator, text mining | PubMed |
| Behçet's spectrum disorders: genetic and immunological insights into an emerging disease concept. | World J Pediatr | 2026 | 42337193 | PubTator, text mining | PubMed |
| The host ubiquitination system dynamically regulates the inflammatory response of macrophages to bacteria. | Front Immunol | 2026 | 42199436 | PubTator, text mining | PubMed |
| Neointimal hyperplasia and vascular restenosis: from molecular mechanisms to therapeutic interventions. | Mol Biomed | 2026 | 42178457 | PubTator, text mining | PubMed |
| Comparing UV-enhanced and direct reduction strategies for CD8⁺ T-cell electrochemical detection. | Sci Rep | 2026 | 42106360 | PubTator, text mining | PubMed |
| Asymmetry in ubiquitin binding by A20 reveals early recognition features of the ubiquitin code. | FEBS Lett | 2026 | 41973842 | PubTator, text mining | PubMed |
| The Ubiquitin-proteasome system in neuroinflammation and neurodegeneration: Molecular insights and therapeutic avenues. | Int Immunopharmacol | 2026 | 41967208 | PubTator, text mining | PubMed |
| Endothelial NEDD4L exacerbates acute lung injury by targeting A20 for ubiquitination degradation. | Respir Res | 2026 | 41943017 | PubTator, text mining | PubMed |
| FBXW11 regulates macrophage polarization and enhances the anti-tumor activity. | Mol Immunol | 2026 | 41934765 | PubTator, text mining | PubMed |
| TCF7L2/DEPDC1 axis contributes to tumor progression by promoting cell proliferation, aerobic glycolysis, and immunosuppression in pancreatic cancer. | Clin Exp Med | 2026 | 41851532 | PubTator, text mining | PubMed |
| Preclinical advances and mechanistic insights of CAR-T therapy for acute myeloid leukemia: from target iteration to microenvironment regulation. | Ann Med | 2026 | 41800605 | PubTator, text mining | PubMed |
| ERG-deficient endothelium identifies IL-8/CXCR2 axis as a therapeutic target for resolving neutrophilic lung vascular injury. | JCI Insight | 2026 | 41785042 | PubTator, text mining | PubMed |
| Meeting abstracts from the Annual Conference "Clinical Genetics of Cancer 2024". | Hered Cancer Clin Pract | 2026 | 41781972 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28935/papers